Wellinq Holding B.V.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Wellinq Holding B.V.
Deal Watch: Novartis Signs Deals In Migraine & Diabetes
Novartis will invest in the Calgary-based Parvus and collaborate on a Navacim candidate for type 1 diabetes. Japan's Sawai moves into the US market by acquiring Upsher-Smith's generics business, while Denovo acquires a suspended depression candidate from AMRI for its personalized development approach.
Deals Shaping the Medical Industry, December 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2016.
- Medical Devices
- Other Names / Subsidiaries
- Blue Medical
- Wellinq Medical
- Wellinq Sensoring
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.